Interestingly, PTEN was a potential target of miR-22-3p in different diseases, including renal cell carcinoma [25], diabetic nephropathy [26] and cisplatin chemosensitivity of gastric cancer [27]. This evidence concerns the gene PTEN and gastric cancer.